HKD 1.28
(4.92%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 228.48 Million USD | -1.57% |
2022 | 232.12 Million USD | -17.79% |
2021 | 282.36 Million USD | -27.36% |
2020 | 388.73 Million USD | 459.34% |
2019 | 69.49 Million USD | -16.77% |
2018 | 83.49 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 219.7 Million USD | 0.0% |
2024 Q1 | 219.7 Million USD | -3.84% |
2023 Q2 | 223.51 Million USD | 0.0% |
2023 Q1 | 223.51 Million USD | -3.71% |
2023 Q4 | 228.48 Million USD | 0.0% |
2023 FY | 228.48 Million USD | -1.57% |
2023 Q3 | 228.48 Million USD | 2.22% |
2022 Q2 | 268.3 Million USD | 0.0% |
2022 FY | 232.12 Million USD | -17.79% |
2022 Q4 | 232.12 Million USD | 0.0% |
2022 Q3 | 232.12 Million USD | -13.49% |
2022 Q1 | 268.3 Million USD | -4.98% |
2021 Q4 | 282.36 Million USD | 0.0% |
2021 Q1 | 327.24 Million USD | -15.82% |
2021 Q2 | 327.24 Million USD | 0.0% |
2021 Q3 | 282.36 Million USD | -13.71% |
2021 FY | 282.36 Million USD | -27.36% |
2020 FY | 388.73 Million USD | 459.34% |
2020 Q4 | 388.73 Million USD | 0.0% |
2020 Q3 | 388.73 Million USD | 216.93% |
2020 Q2 | 122.65 Million USD | 0.0% |
2020 Q1 | 122.65 Million USD | 76.49% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | 69.49 Million USD | 0.0% |
2019 Q4 | 69.49 Million USD | 0.0% |
2019 FY | 69.49 Million USD | -16.77% |
2018 FY | 83.49 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | 44.272% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 97.969% |